Patient Guide: Study to Assess the Efficacy and Safety of Alpelisib Plus Fulvestrant in Participants With HR-positive (HR+), HER2-negative, Advanced Breast Cancer After Treatment With a CDK4/6 Inhibitor and an Aromatase Inhibitor.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 68 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT05038735
Status: ACTIVE_NOT_RECRUITING
Condition: Breast Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 68 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Sint-Niklaas, Oost Vlaanderen
  • Brussels,
  • Brussels,
  • • And 65 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily